IFIH1 and acquired idiopathic inflammatory myopathy: A Japanese cohort study also found that anti-MDA5-positive idiopathic inflammatory myopathy (IIM) cases often progress to fulminant and fatal ILD, with an estimated 30–60% incidence and a six-fold increase in mortality risk compared to anti-MDA5-negative counterparts [41].